Screener
Supernus Pharmaceuticals SUPN Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001356576-26-000022
FAQ
- What is Supernus Pharmaceuticals's net margin?
- Supernus Pharmaceuticals (SUPN) reported net margin of -3.7% in Q1 2026.
- How has Supernus Pharmaceuticals's net margin changed year-over-year?
- Supernus Pharmaceuticals's net margin decreased by 140.3% year-over-year, from 9.3% to -3.7%.
- What is the long-term trend for Supernus Pharmaceuticals's net margin?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's net margin has grown at a -26.1% compound annual growth rate (CAGR), from 24.4% to -5.4%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Supernus Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude